The Efficacy of HD-tDCS-Augmented Step Training in Older Adults With Mild Dementia
The Efficacy of Combined High-definition Transcranial Direct Current Stimulation (HD-tDCS) and Step Training in Older Adults With Mild Dementia: A Randomized Controlled Trial
1 other identifier
interventional
68
1 country
1
Brief Summary
Falls and mobility decline are major health concerns among older adults with dementia, often linked to deterioration in executive function and cognitive-motor control. Step training interventions that challenge both cognitive and motor faculties have shown promise in enhancing balance and motor reaction to reduce fall risk. However, long-term retention of training gains remains limited, largely constrained by reduced neuroplasticity and underlying neurodegeneration in this population. The primary objective of this study is to investigate the efficacy of high-definition transcranial direct current stimulation (HD-tDCS), a form of wearable non-invasive brain stimulation, combined with step training in community-dwelling older adults with mild dementia. Participants will be randomly allocated to either an active HD-tDCS plus step training group or a sham stimulation plus step training control group. Assessments will be conducted at baseline, immediately post-intervention, and at a 3-month follow-up to evaluate changes in cognitive and physical function (including choice stepping reaction time (CSRT), executive function, and dual-task ability) as well as cortical activity during stepping. In addition, a mid-point assessment will be conducted for the primary outcome (i.e., CSRT). An embedded qualitative evaluation will be conducted with participant-caregiver dyads and healthcare professionals/staff to evaluate implementation outcomes and feasibility (including perceived acceptability, user experience, and practical facilitators and barriers to adoption). Findings from this trial will help optimize neuromodulation-augmented rehabilitation strategies and inform community-based fall prevention programs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 19, 2026
CompletedFirst Posted
Study publicly available on registry
September 25, 2026
CompletedStudy Start
First participant enrolled
October 30, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2028
Study Completion
Last participant's last visit for all outcomes
June 30, 2028
September 25, 2026
September 1, 2026
1.4 years
September 19, 2026
September 19, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Choice Stepping Reaction Time (CSRT) Test Completion Time
The clinical Choice Stepping Reaction Time (CSRT) test evaluates goal-directed volitional stepping speed and accuracy. Participants stand on a designated mat and step onto indicated target panels as quickly and accurately as possible in response to standardized verbal cues across 12 test trials. Performance is recorded as the total time (in seconds) required to successfully complete all 12 correct steps using a stopwatch. Shorter completion times indicate faster reaction and better stepping performance.
Baseline, mid-point of intervention (Week 6), immediate post-intervention (Week 12), and 3-month follow-up (Week 24)
Secondary Outcomes (5)
Dorsolateral Prefrontal Cortex (DLPFC) Hemodynamic Response During Choice Stepping
Baseline, immediate post-intervention, and 3-month follow-up
Berg Balance Scale (BBS) Score
Baseline, immediate post-intervention, and 3-month follow-up
Maximum Step Length
Baseline, immediate post-intervention, and 3-month follow-up
Single- and Dual-Task TUG Speed
Baseline, immediate post-intervention, and 3-month follow-up
Trail Making Test (TMT) Score
Baseline, immediate post-intervention, and 3-month follow-up
Other Outcomes (4)
The Iconographic Falls Efficacy Scale (Icon-FES) Score
Baseline, immediate post-intervention, and 3-month follow-up
Geriatric Depression Scale (GDS) Score
Baseline, immediate post-intervention, and 3-month follow-up
Participant and Caregiver Blinding Integrity Assessment
Immediately post-intervention
- +1 more other outcomes
Study Arms (2)
active HD-tDCS plus step training
EXPERIMENTALsham HD-tDCS plus step training
SHAM COMPARATORInterventions
A structured stepping exercise program will be delivered on a designated stepping mat. The intervention incorporates progressive cognitive tasks (including mental arithmetic, working memory, and executive function challenges) combined with directional volitional stepping. Training difficulty is progressively adapted based on individual performance, with physical and cognitive exertion monitored to maintain a moderate intensity level.
The sham HD-tDCS targets the prefrontal cortex via a 4×1 multi-electrode montage during training. The sham HD-tDCS delivers brief current stimulation to simulate scalp sensations without inducing neuroplastic effects to maintain blinding. All sessions are delivered by trained research personnel following standardized safety guidelines.
The active HD-tDCS targets the prefrontal cortex via a 4×1 multi-electrode montage during training. The active HD-tDCS delivers 2 mA current for 20 minutes with ramp-up and ramp-down phases. All sessions are delivered by trained research personnel following standardized safety guidelines.
Eligibility Criteria
You may qualify if:
- Interested persons will be included if they are (1) aged 65 years or older; (2) able to walk 10 m without assistance; (3) can communicate in Chinese; and (4) clinically diagnosed with dementia, with mild-stage severity evidenced by a total score of 10 to 18 (inclusive) on the Hong Kong version of the Montreal Cognitive Assessment (HK-MoCA) \[21\].
You may not qualify if:
- Individuals will be excluded if they, or their caregivers, report: (1) severe cardiopulmonary diseases, severe musculoskeletal disorders, or severe visual or hearing impairments; (2) any neurological conditions other than dementia; (3) contraindications to tDCS, including metallic head implants (excluding dental fillings), cardiac pacemakers, skull defects, a history of unprovoked seizures, or skin/scalp lesions at electrode sites; or (4) concurrent or recent physical therapy or non-invasive brain stimulation within the past 3 months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Hong Kong Polytechnic University
Hong Kong, None Selected, Hong Kong
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marco YC Pang, Chair professor
The Hong Kong Polytechnic University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chair Professor
Study Record Dates
First Submitted
September 19, 2026
First Posted
September 25, 2026
Study Start (Estimated)
October 30, 2026
Primary Completion (Estimated)
March 31, 2028
Study Completion (Estimated)
June 30, 2028
Last Updated
September 25, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP